Interleukin 6 Deficiency Modulates the Hypothalamic Expression of Energy Balance Regulating Peptides during Pregnancy in Mice by Pazos Mendoza, Patricia et al.
Interleukin 6 Deficiency Modulates the Hypothalamic
Expression of Energy Balance Regulating Peptides
during Pregnancy in Mice
Patricia Pazos1,2,3, Luis Lima1,2, Felipe F. Casanueva1,2,3,4, Carlos Diéguez1,2,3, Marı́a C. Garcı́a1,2,3*
1 Department of Physiology/Research Center of Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela, Santiago de Compostela, Spain,
2 Instituto de Investigación Sanitaria de Santiago de Compostela, Santiago de Compostela, Spain, 3 CIBER Fisiopatologı́a Obesidad y Nutrición (CB06/03), Instituto de
Salud Carlos III (ISCIII), Ministerio de Economı́a y Competitividad (MINECO), Santiago de Compostela, Spain, 4 Laboratorio de Endocrinologı́a Molecular y Celular,
Complexo Hospitalario Universitario de Santiago (CHUS), Santiago de Compostela, Spain
Abstract
Pregnancy is associated with hyperphagia, increased adiposity and multiple neuroendocrine adaptations. Maternal adipose
tissue secretes rising amounts of interleukin 6 (IL6), which acts peripherally modulating metabolic function and centrally
increasing energy expenditure and reducing body fat. To explore the role of IL6 in the central mechanisms governing dam’s
energy homeostasis, early, mid and late pregnant (gestational days 7, 13 and 18) wild-type (WT) and Il6 knockout mice (Il6-
KO) were compared with virgin controls at diestrus. Food intake, body weight and composition as well as indirect
calorimetry measurements were performed in vivo. Anabolic and orexigenic peptides: neuropeptide Y (Npy) and agouti-
related peptide (Agrp); and catabolic and anorectic neuropeptides: proopiomelanocortin (Pomc), corticotrophin and
thyrotropin-releasing hormone (Crh and Trh) mRNA levels were determined by in situ hybridization. Real time-PCR and
western-blot were used for additional tissue gene expression and protein studies. Non-pregnant Il6-KO mice were leaner
than WT mice due to a decrease in fat but not in lean body mass. Pregnant Il6-KO mice had higher fat accretion despite
similar body weight gain than WT controls. A decreased fat utilization in absence of Il6 might explain this effect, as shown
by increased respiratory exchange ratio (RER) in virgin Il6-KO mice. Il6 mRNA levels were markedly enhanced in adipose
tissue but reduced in hypothalamus of mid and late pregnant WT mice. Trh expression was also stimulated at gestational
day 13 and lack of Il6 blunted this effect. Conversely, in late pregnant mice lessened hypothalamic Il6 receptor alpha (Il6ra),
Pomc and Crh mRNA were observed. Il6 deficiency during this stage up-regulated Npy and Agrp expression, while restoring
Pomc mRNA levels to virgin values. Together these results demonstrate that IL6/IL6Ra system modulates Npy/Agrp, Pomc
and Trh expression during mouse pregnancy, supporting a role of IL6 in the central regulation of body fat in this
physiological state.
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Introduction
Energy balance is largely regulated by the central nervous
system (CNS) via a homeostatic system. Central regulatory
networks, located mainly in the hypothalamus and brainstem,
sense metabolic status from widely divergent afferent signals
(hormones, nutrients and neural signals) and modify the expression
and release of specific neurotransmitters/neuromodulators with
potent effects on energy intake and expenditure [1,2]. Distur-
bances in the activity of these central circuitries and/or peripheral
signaling pathways may lead to changes in feeding behavior,
substrate metabolism and energy expenditure; ultimately favoring
an adjustment of body weight and body composition [3].
Afferent endocrine signals encoding energy status may arise
from different sites including: i) fat, which secretes adipokines such
as leptin, adiponectin, resistin and interleukin-6 (IL6), ii) pancreas,
which produces insulin and iii) gastrointestinal organs, which
release hormones such as ghrelin, glucagon-like peptide I and
peptide YY [1,4,5]. Within the hypothalamus, two functionally
opposing subpopulations of neurons in the arcuate nucleus (ARC)
represent a key integrative site for these signals. One subpopula-
tion produces gamma aminobutyric-acid (GABA) and the
orexigenic neuropeptideY (NPY) and agouti-related peptide
(AGRP). The other produces cocaine and amphetamine regulated
transcript (CART) and proopiomelanocortin (POMC)-derived
peptides, such as alpha melanocyte stimulating hormone (aMSH),
that promote anorexia by inhibiting food intake and increasing
catabolic processes. aMSH modulate its downstream homeostatic
signaling via their action at melanocortin receptors MC3R and
MC4R, which are antagonized by AGRP [3]. Additionally,
AGRP/NPY neurons block the aMSH effects by activating NPY
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receptors (Y1-Y5) on the MC4-R bearing cells and through direct
and indirect GABA-ergic inhibitory inputs [6].
Both groups of cells project to several brain areas such as the
paraventricular nucleus (PVN) and lateral hypothalamic area
(LHA). The major neurotransmitters released from the PVN
include: oxytocin, arginine-vasopressin (AVP), corticotrophin and
thyrotropin-releasing hormone (CRH and TRH) [7]. CRH and
TRH have rather overlapping roles in the control of energy
balance. Thus, central administration of both neuropeptides
decreases food intake and increases locomotor activity, oxygen
consumption and brown adipose tissue thermogenesis. These
effects maybe exerted directly at the CNS, modulating autonomic
function, or via the hypothalamic-pituitary adrenal and thyroid
axes (HPA and HPT), inducing glucocorticoid and thyroid
hormone release [7–10].
IL6 is a pleiotropic immunomodulatory cytokine produced not
only by the cells of immune system but also by cells in
neuroendocrine and endocrine tissues, such as those in the
hypothalamus, adipose tissue, skeletal muscle and reproductive
organs [11]. Over the last decade this cytokine has attracted
particular attention because of its regulatory role on peripheral
lipid metabolism [12–14] and contradictory multi-systemic effects
on insulin action [15–19]. Growing evidence suggest that centrally
acting IL6 could also have a physiological role in the regulation of
food intake, energy expenditure and adiposity. Obesity, exercise
and diabetes are associated with elevated plasma IL6 concentra-
tions while cerebrospinal fluid (CSF) IL6 levels remain unchanged
[20,21]. However, IL6 is found in the CNS in health and disease,
with cellular sources being glial cells and neurons [22], and might
regulate the hypothalamic circuits involved in energy homeostasis
in a gender and age dependent manner. Intracerebroventricular,
but not peripheral IL6 administration, increases energy expendi-
ture and reduces food intake and weight of visceral fat depots
[14,23]. In fact, transgenic female mice with CNS-restricted Il6
over-expression show decreased Npy and Agrp mRNA levels at all
ages, and a late increase in Pomc expression in the arcuate nucleus
(ARC) [24]. Conversely, Il6 deficiency in mice decreases fat
oxidation [13,25,26] and leads to a mature onset obese phenotype
[14], which is accompanied by reduced expression of energy
balance regulating peptides in the PVN [27]. The IL6 receptor
alpha (IL6Ra), crucial for ligand binding, has been shown to be
abundantly produced in the PVN and co-expressed to a high
extent with CRH, AVP, oxytocin and TRH suggesting that IL6
could stimulate the expression of these peptides directly [27].
During pregnancy adjustments are made to mother’s homeo-
static mechanisms that regulate food intake and the metabolism of
nutrients [28,29]. Changes in lipid metabolism result in accumu-
lation of maternal fat stores in early and mid-pregnancy, and
enhance fat mobilization in late pregnancy. In the early stage,
promotion of lipogenesis and reduced lipolysis are mediated by
increased insulin sensitivity and secretion as well as progesterone
levels. This anabolic hormonal milieu is reinforced by the
development of maternal hyperphagia, which is sustained
throughout pregnancy [30,31]. As pregnancy proceeds, insulin
sensitivity is impaired and lipolysis and fat oxidation are enhanced,
allowing the use of lipids as maternal energy source [32]. In this
context, a progressive increase in adipose tissue production and
serum levels of different adipokines as leptin, resistin and IL6 has
been reported in both rodent and human pregnancies [33–37]. In
the pregnant rat, circulating IL6 levels are enhanced during the
entire gestational period and paralleled its CSF concentration
during early and mid-stages but, similarly to leptin CSF levels,
decreased to virgin control values in late pregnancy [35]. At this
gestational time the ARC neural pathways influencing food
consumption are activated, leading to an increased Npy and Agrp
expression and a decline in Pomc mRNA content [31,38].
Moreover throughout most of pregnancy, but also in lactation,
the basal activity of the HPA axis is inhibited, predominantly
reflecting a reduced drive by CRH and AVP neurons in the PVN
[39]. However, despite these circumstantial evidences, the relative
importance of IL6 as a central regulator of food intake and
adiposity during pregnancy remains to be demonstrated. Thus, in
the present study we sought to determine whether pregnancy-
related changes in ARC and PVN circuitries involved in energy
homeostasis are affected by knockout of Il6 in mice (Il6-KO). We
also investigated whether the putative effects of endogenous IL6
could be mediated by changes in hypothalamic Il6ra expression
during this physiological state.
Materials and Methods
Animals
B6.129S2-IL6 tm1kopf/J (Il6-KO) [40], that had undergone
eleven backcrosses to the C57BL/6 background and their
congenic wild-type controls C57BL/6J mice (WT) were purchased
from Jackson laboratories (Charles River, Barcelona, Spain; stock
numbers 002650 and 000664, respectively). Since the Il6 mutation
is maintained in the C57BL/6J 000664 background, WT and Il6-
KO mice colonies were bred on homozygous conditions and
maintained in the same room of the Santiago de Compostela
Animal house under specific pathogen-free conditions (SPF). The
absence of full-length Il6 transcripts in Il6-KO mice was confirmed
by RT-PCR. After weaning, animals were housed 5–6 per cage
under controlled temperature conditions (22uC) and a 12 hour
light-dark cycle, with free access to water and rodent chow (2019 s,
Teklad Global, Harlan, Spain). Age matched female WT and Il6-
KO mice (12–15 weeks old) were always used and allocated to
either virgin (unmated) or pregnant groups prior to the start of the
experiments. To obtain pregnant animals, female Il6-KO and WT
mice were mated with stud mice of the same genotype and timed
pregnant from the day the vaginal plug was detected (day 0 post
coitum). Ethical approval was obtained from the University of
Santiago de Compostela Bio-ethics Committee (ID: PX06/
208067) and all the procedures were conducted according to the
regulations of the European Community.
Experimental design
In a first experiment, food intake and body weight were
monitored daily for 18 days in single housed virgin and pregnant,
12 weeks old WT and Il6-KO mice (n = 15–16 animals/pregnant
group and n= 21 animals/virgin group). Body length was
measured on an independent group of sedated virgin WT and
Il6-KO mice with a ruler from nose to anus (n = 6 animals/group).
At the end of study period half of the pregnant mice were either
sacrificed (n= 8 animals/group) or allowed to give birth naturally
(n = 7–8/group). Combined weight of placentae and fetuses as well
as newborn mice body weight were measured.
In a second study, longitudinal measurements of whole-fat
content were carried out in groups of 15 weeks old unmated and
mated mice at gestational days 7, 13 and 18 (corresponding to
early, mid and late pregnancy, respectively) (n = 9–10 animals/
pregnant group n= 5–7 animals/virgin group) using a nuclear
magnetic resonance (NMR) spectroscopy device EchoMRI-700TM
(Echo Medical Systems, Houston, TX). Transversal analysis of
specific fat depots and sample collection for subsequent expression
studies by real-time quantitative RT-PCR were performed in
12 weeks old mice. Animals were time pregnant and on the
corresponding date of pregnancy were anesthetized, and after
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collection of serum samples by cardiac puncture, were sacrificed
by decapitation. Age and genotype matched virgin females,
identified as diestrus by vaginal cytology, were used as controls
(gestational days 7 (n = 15/pregnant group and n= 14–16/virgin
group), 13 (n = 18–20/pregnant group and n= 18–21/virgin
group) or 18 (n= 22–24/pregnant group and n= 24–25/virgin
group). Dissection and weighing of intra-abdominal (mesenteric,
gonadal and retroperitoneal) and subcutaneous fat depots was
performed as previously described [41]. Abdominal fat distribution
was determined as percentage of the combined weight of the
dissected depots from non pregnant controls of the same genotype.
Gonadal and brown adipose tissue samples (BAT), complete brains
or whole hypothalami were removed, quickly frozen on dry ice
and stored at –80uC prior to analysis of Il6, Il6ra or neuropeptide
expression.
In a third experiment energy expenditure and respiratory
exchange ratio (RER=VCO2/VO2) were measured in 12 weeks
old virgin WT and Il6-KO mice. Animals were monitored in a 12-
cage indirect calorimetry, food intake and locomotor activity
monitoring system (TSE LabMaster, TSE Systems, Bad Hom-
burg, Germany) as previously described [42]. Mice were
acclimated for 48 hr to the test chambers and then were
monitored for an additional 24 hr. Measurements were taken
every 40 minutes. Data collected from the last 24 hr were used to
calculate energy expenditure and average RER during 12 h-light
and 12 h-dark phases of the daily cycle.
Serum assays
Circulating serum levels of C-reactive protein (CRP), leptin and
interleukin 6 were assayed by ELISA, using commercial kits (CRP,
Life Diagnostics, Knypersley, UK; Leptin, Crystal Chem,
Downers Grove, IL, USA and IL6, Abcam, Cambridge, UK)
according to the manufacturer’s instructions.
In situ hybridization
Serial 16 mm-thick coronal sections were cut on a cryostat at
220uC, mounted onto polylysine-coated slides (Thermo Scientific,
Spain) and immediately stored at 280uC. Npy, Agrp, Pomc, Trh and
Crh mRNA levels were determined using 42-45-mer specific
antisense oligo-probes (Table S1 in File S1). The probes were 39-
end labeled with 35S-adATP (1250 Ci/mmol; Perkin-Elmer,
Boston, USA) and terminal deoxynucleotidyl transferase (New
England BioLabs, UK). Specificity of the hybridization signal was
confirmed by performing co-hybridization studies with an excess
of unlabeled probes (not shown). In situ hybridization was carried
out as previously described [38]. Tissue sections were fixed with
4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4) at room
temperature for 30 min, dehydrated through 70, 80, 90, 95% and
absolute ethanol (5 min each). Sections were removed from
ethanol, allowed to dry and hybridized overnight in a humid
chamber at 42uC, in a hybridization solution containing 46SSC,
50% deionized formamide, 16 Denhardt’s solution, 10 mg/mL
sheared single-stranded salmon sperm DNA, 10% dextran sulfate,
DTT 50 mM and 0.5–16106 cpm/slide of the labeled probes.
After hybridization, sections were rinsed in 1xSSC at room
temperature, sequentially washed in 1xSSC at 55uC (30 min/
wash, 4 washes in total) and room temperature for 1 h, and finally
rinsed in 70% ethanol with 300 mM ammonium acetate. After
air-dried hybridized sections were apposed to autoradiography
film (Kodak Biomax MR) at room temperature for 5 days (Npy,
Agrp, Pomc, Trh mRNA) and 7 days (Crh mRNA).
To compare anatomically similar regions, slides were matched
according to the mouse atlas of Franklin and Paxinos [43]. In each
experiment with a specific transcript the slides (3–4 slides per
animal/4 sections in each slide) from at least three to four control
virgin and pregnant mice, at each gestational age, were processed
together and were always exposed to the same autoradiographic
film. Autorradiographic images were scanned and the optical
density of the specific hybridization signal was quantified using the
image analysis software ImageJ 1.40 (National Institutes of Health,
USA).
Real time qPCR
Real time quantitative RT-PCR (qPCR) analysis was carried
out as previously described [44]. Total RNA was extracted from
frozen abdominal white adipose tissue (WAT), hypothalami or
brown adipose tissue (BAT) using TRIzol according to the
manufacturer’s instructions (Invitrogen, Barcelona, Spain). Com-
plementary DNAs were synthesized from 500 ng of total RNA in a
30 ml reaction using 200 U Maloney murine leukemia virus
reverse transcriptase and random hexamer primers (Invitrogen,
Barcelona, Spain). Quantitative real time PCR was performed
using an ABI PRISM 7300HT Sequence Detection System
(Applied Biosystems; Foster City, CA, USA), with 2 ml aliquots of
the resulting cDNAs and specific Taqman qRT-PCR primers and
probes for Il6, Il6ra, Ucp1 and Ucp3 (Table S1 in File S1).
Amplification of 18S rRNA (Rn18S) was performed at the same
time to normalize the level of mRNA expression. A non template
reaction was included during each experiment to control for DNA
contamination. The PCR cycling conditions included an initial
denaturation at 50uC for 10 min, followed by 40 cycles at 95uC for
15 s and 60uC for 1 min. A standard curve was run in each assay,
with an arbitrary value assigned to the highest standard and
corresponding values to the subsequent dilutions. Each cDNA
sample was run in duplicate. The relative abundance of Il6, Il6ra,
Ucp1 and Ucp3 targets were normalized against that of Rn18s and
expressed in percentage respect to the average value of the WT
virgin control group.
Western-blot
Western-blots were performed as previously described [44].
Briefly, total protein lysates from BAT (20 mg) samples were
subjected to SDS-PAGE, electrotransferred onto a polyvinylidene
difluoride membrane (Immobilon-P, Millipore, Billerica, MA,
USA) and probed with antibodies against UCP1 (ab10983), UCP3
(ab3477, Abcam, Cambridge, UK) and alpha-tubulin (T5168,
Sigma-Aldrich, St. Louis, MO, USA). The antibodies dilution was
1:1000. For protein detection biotinylated secondary antibody
conjugates, diluted (1:5000) and chemiluminescence (Thermo
Fisher Scientific, Madrid, Spain) were used. Protein levels were
normalized to alpha-tubulin for each sample and expressed in
percentage respect to the average value of the WT virgin control
group.
Oil-Red staining
Frozen BAT samples preserved in OCT were cryosectioned into
10 mM sections, mounted onto microscope slides and stored at
210uC until staining. Slides were allowed to acclimate to room
temperature for approximately 10–15 min prior to staining. Tissue
was then fixed in 10% neutral buffered formalin for 5 min and
briefly washed in water. The slides were then rinsed in 60%
isopropanol and placed into freshly prepared Oil Red O working
solution (Sigma-Aldrich, St. Louis, MO, USA). Slides were
allowed to stain for 15 min at room temperature. After staining,
slides were rinsed with 60% isopropanol and the nuclei were
lightly stained with hematoxylin stain (Sigma-Aldrich, St. Louis,
MO, USA). Lastly, the slides were washed 3 times in water and
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coverslips were applied using aqueous mounting media. The slides
were then visualized on a light microscope at 106magnification.
Statistical analysis
Results are given as means 6 SEM. All data were analyzed
using Graph Pad Prism version 6.00 for Windows (GraphPad
Software, La Jolla, California USA). Comparisons between two
groups were performed with unpaired two-tailed Student’s t test
and one-way analysis of variance (ANOVA), followed by the
Bonferroni post hoc test, when differences between more than two
experimental groups were analyzed. Data derived from the same
animals at several times were analyzed with two-way ANOVA for
repeated measurements to evaluate differences between experi-
mental groups. P,0.05 was considered statistically significant.
Results
Il6-KO mice show similar weight gain and fat mass but
higher fat accretion than WT mice during pregnancy
Firstly, we studied the effect of lack of endogenous Il6 in the
pregnancy-related changes on body weight (Figure 1A). The mean
body weight of 12 weeks-old Il6-KO female mice used in this
study, unmated or mated, was lower than that of WT mice
(average body weight at day 0 of pregnancy: WT mice
= 23.3660.24 g versus Il6-KO mice = 21.5660.23 g, P,0.001,
t-test). There were no differences in their longitudinal length at this
age between genotypes (WT mice = 8.83360.06 cm versus Il6-
KO mice = 8.81660.075 cm). Maternal body weight increased
exponentially throughout pregnancy, but remained a 7% lower in
the Il6-KO pregnant than in WT pregnant group until gestational
day 18 (genotype F (1, 29) = 28.41, time F (18, 522) = 1002,
P,0.0001 and genotype X time interaction F (18, 522) = 0.8435,
not significant, two-way repeated measures ANOVA). A similar
genotype effect was observed on the weight of non pregnant
groups (genotype F (1, 40) = 14.75, time F (18, 720) = 18.74 and
genotype X time interaction F (18, 720) = 2.326, P,0.001,
P,0.0001 and P,0.001, respectively). However, the body weight
gain was similar in WT and Il6-KO mice whether pregnant or not
in all time points studied, with values for virgin groups at the end
of the 18 days-study period of: WT mice = 1.02460.242 g versus
Il6-KO mice = 0.67660.150; and pregnant groups of: WT mice
= 16.67260.619 g versus Il6-KO mice = 15.85460.835 g
(Figure 1B). The mean number and weight of embryos and
placentae in uteri of 18-days pregnant mice were also similar
between genotypes, as were the litter sizes and the weight of
newborn mice at birth (Table S2 in File S2).
Taking into account that expansion of fatty tissue, besides
conceptus growth, is the main contributor to gestational weight gain
[30,32], we therefore evaluated body fat mass by NMR in 15 weeks
old mice WT and Il6-KOmice throughout pregnancy. As expected
[26] in 15 weeks old non-pregnant adult, Il6-KO mice had a lower
total fat mass content thanWTmice during the NMR study (218%
as a mean, genotype F (1, 10) = 18.26, time F (2, 20) = 11.06,
P,0.01 and genotype X time F (2, 20) = 0.107, P = 0.899, two-way
repeated measures ANOVA) (Figure 1C). As a significant overall
effect of genotype was detected, a Bonferroni post-test was applied
for the pairwise comparison (e.g. fat mass of virgin WT
=2.36660.117 g vs fat mass of virgin Il6-KO at day
7= 1.86660.095 g). The results for genotype effect were significant
at day 7, 13 and 18 (P,0.01, P,0.05 and P,0.05, respectively). No
effect of Il6 deficiency was seen in lean bodymass values, whichwere
similar in virgin WT and Il6-KO mice at the beginning (WT mice
= 17.50560.435 g versus Il6-KO mice = 16.63460.501 g) and at
the end of the experimental period (WT mice = 18.25260.465 g
versus Il6-KOmice = 17.44460.382 g) (Figure S1A in File S3). On
the contrary, pregnancy in all its phases is able to revert the effect of
Il6 deficiency on total adipose tissue levels (genotype F (1, 18)
= 0.0007, P = 0.978 and time F (2, 36) = 38.82, P , 0.0001).
Nevertheless, we did observe a trend to lower lean body mass values
in Il6-KO pregnant mice in relation to their WT controls, which
reached statistical significance only in late pregnant animals when
expressed in absolute (Figure S1A in File S3) but not relative to body
weight values (Figure S1B in File S3).
Since Il6-KO mice appeared to have higher fat mass accretion
than WTmice during pregnancy, dissection of specific fat depots in
independent groups of 12 weeks old animals was performed at
gestational days 7, 13 and 18 (early, mid and late pregnant,
respectively). Thus, confirming the NMR data, the absolute and
relative weights of visceral fat pads in all groups of non-pregnant Il6-
KO mice were lower than those of corresponding WT virgin
controls (on average: 222, 223 and 220%, P,0.05, one-way
ANOVA) (Figure 1D, E and F, left and middle panel). Both
parameters were similar in pregnant mice of both genotypes at each
stage of gestation. As expected, early,mid and late pregnantWTand
Il6-KO mice also exhibited an increased absolute visceral fat,
compared to virgin controls of each genotype (P,0.05, P,0.01 and
P,0.01, respectively) (Figure 1D, E and F, left panel). However,
when these values are corrected by body weight, the differences
between pregnant and virgin mice of each genotype were significant
only at early and mid, but not at late pregnancy (P,0.05 for all)
(Figure 1D, E and F, middle panel). At gestational day 18, pregnant
Il6-KO mice showed higher levels of relative fat mass than
corresponding virgin controls, with no differences between WT
mice groups (P,0.01) (Figure 1F, middle panel). Analysis of relative
abdominal fat mass content in relation to non-pregnant mice values
in each genotype revealed that, early and late-pregnant Il6-KOmice
showed 30 and 16% higher fat accretion thanWTmice (P,0.01 for
early and late-pregnant groups by t-test) (Figure 1D and F, left
panel). A similar effect of lack of Il6 on fat accretion was observed in
subcutaneous adipose tissue of early and mid-pregnant mice
(Figure S2A and B in File S4).
Additionally, serum leptin levels were also quantified in samples
from virgin and late pregnant WT and Il6-KO mice. As previously
described [45,46], by the end of pregnancy serum leptin levels
were markedly higher than those in non-pregnant mice in both
genotypes (P,0.001, one-way ANOVA) (Figure S3 in File S5). In
agreement with the fat mass results, virgin but not pregnant Il6-
KO mice showed significantly lower serum leptin concentrations
that their correspondent WT controls (P,0.05).
Lack of Il6 does not affect relative food intake during
pregnancy
Next, we evaluated whether the profile of fat accretion in Il6-
KO pregnant mice was related to changes in average daily food
intake during early (gestational days 0–7), mid (gestational days 7–
13) and late gestation (gestational days 13–18) (Figure 2). Non-
pregnant 12 weeks old Il6-KO mice ate less amount of food than
their corresponding WT controls when values are expressed on an
absolute (27,3% as a mean, Figure 2A), but not on a weight
corrected basis (Figure 2B) (absolute: genotype F (1, 40) = 17.86, P
, 0.001, time F (2, 80) = 5.823, P , 0,01 and genotype X time F
(2, 80) = 1.180, not significant, two-way repeated measures
ANOVA), (relative: time F (2, 80) = 5.581, P,0.01, genotype F
(1, 40) = 0.0246 and genotype X time F (2, 80) = 0.322, not
significant). Food consumption increased progressively during
pregnancy (group F (3, 69) = 55.61, time F (2, 138) = 81.32 and
group X time F (6, 138) = 15.13, P , 0.0001 for all), and was
higher than non-pregnant levels by its first week (P,0.05,
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Figure 2A). At this time point absolute food intake values were
similar in both genotypes, being lower in Il6-KO than in WT mice
throughout the rest of the gestational period (genotype F (1, 29)
= 15.33, P , 0.001, time F (2, 58) = 125.7, P , 0.001 and
genotype X time F (2, 58) = 4.324, P,0.05) (gestational days 13
and 18: P,0.01 and P,0.001, respectively). However, when food
intake values in pregnant mice were corrected by body mass no
effect of Il6 deficiency was seen in this parameter (Figure 2B)
(genotype F (1, 29) = 0.151, P = 0.443, time F (2, 58) = 25.521, P
, 0.0001 and genotype X time F (2, 58) = 3.367, P,0.05).
Lack of Il6 increases respiratory exchange ratio in virgin
mice
In order to ascertain whether changes in energy expenditure or
metabolic substrate preference (RER) in Il6-KO mice could
induce the subsequent fat accumulation during pregnancy, both
parameters were analyzed by indirect calorimetry. To overcome
the contribution of fetal lean body mass to the analysis, 12 weeks
old virgin WT and Il6-KO mice were used in this study. Il6-KO
mice showed an increased RER in comparison with WT mice
(Figure 3A) (genotype F (1,10) = 6.268, P,0.05, time F (35,350)
= 1464 and genotype X time interaction F (35, 350) = 1,206, not
significant, two-way repeated measures ANOVA) during both the
Figure 1. Normal body weight gain, fat mass but higher abdominal fat accretion in pregnant Il6-KO mice. A–B. Body weight (A) and
change in body mass (B) were monitored daily in 12 weeks old mated (n = 15–16) and unmated WT and Il6-KO mice (n = 21). C. Longitudinal
measurements of NMR fat were performed in 15 weeks old mice at gestational days 7, 13 and 18 (virgin, n = 5–7 and pregnan, t n = 9–10). D–F. For
transversal analysis of absolute (right panel) and relative dissected abdominal fat mass (middle and left panel), independent groups of 12 weeks old
time-pregnant mice were sacrificed on gestational days 7 (D, n = 8–9), 13 (E, n = 8–9) and 18 (F, n = 11). Age and genotype matched virgin females
were used as controls (n = 7–11). Relative fat mass values were calculated in percentage to maternal body weight (middle panel), excluding the
contribution of placentae and fetuses, and normalized to virgin control values of each genotype (F). Data are expressed as mean 6 SEM. One-way
ANOVA and two-way ANOVA for repeated measurements, *P,0.05, **P,0.01,***P ,0.001 and ****P,0.0001, ns = not significant; two-tailed t-test
##P,0.01 versus corresponding WT pregnant controls.
doi:10.1371/journal.pone.0072339.g001
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light and dark phases of the circadian cycle (P,0.05) (Figure 3A,
right panel), suggesting that a low lipid-to-carbohydrate oxidation
could contribute to normalize its fat stores during pregnancy. No
significant differences in total energy expenditure, when corrected
by body weight (Figure 3B) or lean body mass (Figure 3C), were
detected. On the contrary, indications of an altered BAT
thermogenic capacity of Il6-KO pregnant mice were observed,
suggesting that lack of Il6 might cause a decrease in energy
expenditure during pregnancy. Therefore, lower Ucp1 and Ucp3
mRNA levels (Figure S4A and B in File S6) and increased lipid
content (Figure S4E in File S6), as measured by increased oil-red
staining, were found in BAT of mid-pregnant Il6-KO in
comparison to WT pregnant controls. However, these observa-
tions were confirmed by western blot studies in the case of UCP3
but not UCP1 (Figure S4C and D in File S6).
Increased serum IL6 and CRP levels during pregnancy in
WT mice
Circulating levels of IL6 and CRP were also assessed during
pregnancy. As expected [37], serum IL6 levels increased as
pregnancy progressed and started to be statistically different from
non pregnant values at gestational day 13 (P,0.05, Figure 4A).
Although serum levels of CRP showed a tendency to be higher in
the mid-pregnant than in the virgin group (P= 0.08, Figure 4B), a
significant stimulatory effect was only evident at gestational day 18
(P,0.01).
Il6 mRNA expression increased in WAT while Il6 and Il6ra
mRNA decreased in the hypothalamus of pregnant WT
mice
Adipose tissue Il6 mRNA expression increased as pregnancy
progressed. Il6 mRNA levels were similar in adipose tissue of
virgin and 7 days pregnant WT mice, but increased three fold on
gestational days 13 and 18 (Figure 5A, percentage of WT virgin
values at gestational days 13 and 18: 303.71671.20 and
255.32642,39, P,0.01, t-test). Conversely, hypothalamic Il6
mRNA levels were a 60 and 50% lower in mid- and late pregnant
mice than in corresponding virgin controls (Figure 5B, P,0.01).
Hypothalamic Il6ra mRNA showed a slightly different profile
during pregnancy from that of Il6, with decreased expression levels
in pregnant mice at gestational days 7 and 18 in comparison to
non-pregnant values (P,0.05, Figure 5C).
Recent published results [47] indicate that CNS (astrocyte-
specific) deletion of Il6 in female mice reduces IL6 receptor
immunoreactivity in the cerebellum, but not in other brain areas
such as hippocampus and cortex. Therefore, in order to confirm
whether the observed reduction in hypothalamic Il6ra expression
could be mediated by IL6 (whether of central or peripheral origin),
the effect of total Il6 deficiency on hypothalamic Il6ra mRNA
levels at gestational days 7, 13 and 18 was also assessed (Figure 6A,
B and C). Lack of Il6 caused a significant inhibition on
hypothalamic Il6ra mRNA content in virgin, early and mid-
pregnant (p,0.05, P,0.05 and P,0.01, respectively, one-way
ANOVA), but not in late pregnant mice (Figure 6C). These results
suggest that at least in the non-pregnant state and at early and mid
pregnancy, IL6 exerts a stimulatory effect on the hypothalamic
expression of its receptor. However, the similar hypothalamic Il6ra
mRNA content in late pregnant WT and Il6-KO mice probably
reflects a compensatory mechanism during this stage of pregnancy.
Npy, Agrp and Pomc mRNA expression in the ARC are
up-regulated in Il6 deficiency during late-pregnancy
In the pregnant rat, food intake and adiposity increases as a
result of the resetting of central appetite control mechanisms at the
level of the ARC, which leads to increased Npy/Agrp and decreased
Pomc mRNA levels [31]. Thus, the effect of Il6 deficiency on Npy/
Agrp and Pomc gene expression during pregnancy was assessed by in
situ hybridization. Nevertheless, our data showed that the Npy and
Agrp expression in the ARC were not altered during normal
pregnancy in the mouse (Figure 7A and B), whereas hypothalamic
Pomc mRNA content in mid- and late pregnant mice were lower
than in virgin animals (237% as a mean, P,0.05, one-way
ANOVA) (Figure 7C). As expected [17], the mRNA levels of all
neuropeptides were unchanged by knockout of Il6 in virgin female
mice (Figure 7A, B and C). Instead, in mid and late pregnant
animals, Il6 deficiency caused a significant rise in Npy/Agrp
expression as compared to non-pregnant mice and completely
reverted the inhibitory effect of pregnancy on hypothalamic Pomc
mRNA content (P,0.001 and P,0.05, for mid and late pregnant
WT versus Il6-KO mice, respectively, one-way ANOVA).
Lack of Il6 down-regulates Trh mRNA expression in the
PVN during mid-pregnancy
The aforementioned gestational changes in the hypothalamic
peptidergic systems involved in the regulation of food intake and
energy expenditure are not restricted to the ARC. In fact, the
principal neuroendocrine outputs from the PVN, the parvicellular
Figure 2. Average daily intake in Il6-KO mice throughout
pregnancy. Food intake was measured daily in individually housed
12 weeks old virgin (n = 21) and pregnant WT and Il6-KO mice (n = 15–
16). A–B. Average daily intake (A) was calculated for early (gestational
days 0–7), mid (gestational days 7–13) and late pregnancy (gestational
days 13–18). Food intake values normalized in percentage to animal
body weight (B). Two-way ANOVA for repeated measurements,
*P,0.05, **P,0.01, ***P ,0.001 and ****P,0.0001, ns = not significant.
doi:10.1371/journal.pone.0072339.g002
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secretory neurons producing Trh and Crh are also affected [48].
Thus, the pattern of mRNA expression in the PVN of Crh and Trh
was assessed during pregnancy, as were the influence of Il6
deficiency on this setting. Our results showed that mRNA levels of
Crh were decreased throughout gestation (234% as a mean,
P,0.05 for virgin versus pregnant WT mice at gestational days 7,
13 and 18, one-way ANOVA) (Figure 8A). This inhibition was
similar in all pregnancy stages, as were the Crh mRNA content in
the PVN from WT and Il6-KO in the virgin and pregnant groups,
respectively.
Finally, the PVN pro-Trh mRNA levels, which were unaffected
during early and late pregnancy in WT mice, were significantly
increased on gestational day 13 in comparison to virgin animals
(P,0.01, one way ANOVA, Figure 8B). Though, the Trh
transcriptional expression was not modulated by Il6 deficiency in
the non-pregnant state, lack of Il6 completely blunted the mid-
pregnancy up-regulation of Trh mRNA levels (P,0.0001 for
13 days-pregnant WT mice versus Il6-KO mice).
Discussion
Pregnancy is an excellent physiological model for studying how
the CNS integrates peripheral signals, conveying information
about the short- and long-term energy metabolic status of the body
such as leptin, insulin or cholecystokinin, to alter hypothalamic
function regulating food intake/energy balance and reproduction
[49]. We report herein that IL6, an adipokine produced by the
expanding adipose tissue, the hypothalamus and perhaps from
other maternal sources like the placenta [50,51], contributes to the
neuroendocrine adaptation that occur in the dam’s brain during
this physiological demanding time.
Figure 3. Increased respiratory exchange ratio in Il6-KO mice. A–C. Respiratory exchange ratio (RER) (A), energy expenditure corrected by
body weight (B) and lean mass (C) were measured in young (12 weeks old) WT and Il6-KO female mice at room temperature. Black horizontal bars
depict the dark period in a 12:12-h light-dark cycle. Data were collected during a 24-h period (8:00 a.m. till 8:00 a.m.). Average values of RER as well as
body weight and lean mass corrected energy expenditure are shown in right panels. Values are expressed as means 6 SEM, n = 6. Two-way ANOVA
for repeated measurements, *P , 0.05 and two-tailed t-test, #P,0.05 for Il6-KO versus WT mice.
doi:10.1371/journal.pone.0072339.g003
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Several studies point to a role of IL6 system as a key pathway
involved in the central regulation of energy balance. Centrally but
not peripherally administered IL6 reduces adiposity mainly by
increasing energy expenditure [14] and thermogenesis [52], and to
a lesser extent by decreasing food intake [23]. To address the
possible role of IL6 in the central mechanisms associated to
maternal hyperphagia and increased adiposity during pregnancy,
in the present study we have used Il6-KO mice as a model.
Therefore, young (12–15 weeks old) pregnant WT and Il6-KO
mice were followed throughout gestation and their body weight,
body composition and food intake was compared to those of non
pregnant animals of both genotypes. As previously reported [26],
we observed that Il6-KO female mice had lower body weight than
WT mice due to a decrease in fat but not in lean body mass, body
length or relative food intake. However, during pregnancy Il6-KO
mice showed higher fat accretion than their WT controls, but
similar fat mass and leptin levels prior parturition. This effect is not
mediated by an increase in food intake in Il6-KO pregnant mice,
whose food consumption in a weight corrected basis was similar to
that of pregnant WT mice. Hence, taking into account the slight
effect of Il6 deficiency on maternal fat deposition observed in this
study, it could be considered that IL6 is not of importance in the
regulation of adiposity during this physiological setting. However,
another alternative interpretation maybe that the increased fat
mass gain in pregnant Il6-KO mice would be the end result of
subtle mismatches between energy intake and the different
components of energy expenditure.
Primary components of daily total energy expenditure include
factors such as basal metabolic rate as well as the specific energy
invested by animals on nutrient absorption/processing, diet-
induced thermogenesis, non-shivering thermogenesis, and loco-
motor activity [53]. Small differences in these parameters between
Figure 4. Serum IL6 and CRP levels during pregnancy in WT
and Il6-KO mice. A–B. Serum IL6 (A) and CRP (B) levels as assessed by
ELISA in virgin and pregnant WT mice at gestational days 7, 13 and 18
(n = 6–7). D. Serum CRP levels in virgin and late pregnant WT and Il6-KO
mice. Data are expressed as mean 6 SEM. One-way ANOVA, *P,0.05,
**P,0.01.
doi:10.1371/journal.pone.0072339.g004
Figure 5. Reduced hypothalamic Il6 and Il6ra but increased
WAT Il6 mRNA expression in pregnant WT mice. 12 weeks old WT
(C57BL6) mice were time-pregnant and samples for RNA extractions
were obtained from WAT and hypothalamus at early, mid and late
pregnancy: gestational days 7 (n = 5), 13 (n = 8) and 18 (n = 6),
respectively. Age matched virgin females were used as controls
(n = 5–9). A–C. Gestational expression pattern of Il6 mRNA in adipose
tissue (A) and hypothalamus (B), and hypothalamic Il6ra mRNA levels (C)
were determined by RT-qPCR. Expression of genes were measured in
duplicates, normalized to 18s and expressed in percentage to WT virgin
control values. The bars represent the mean 6 SEM. Two-tailed t-test,
*P,0.05 and **P,0.01 versus corresponding WT virgin controls.
doi:10.1371/journal.pone.0072339.g005
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control and mutant mice, only evident after challenging conditions
such as high fat diet feeding or cold exposure, might contribute
under basal conditions to cumulative increments in fat mass and
eventually to obesity [25,41]. Detailed observation of the Il6-KO
mice phenotype at young and late ages has been performed in
several previous studies. Though Il6-KO mice may exhibit a lean
phenotype at young age [26], it has been reported that Il6
deficiency leads to obesity in the maturity without affecting feeding
behaviour [14,26,54]. Faldt et al [26] but also Wernstedt et al [13]
observed that pre-obese Il6 deficient mice had a higher RER than
their WT controls, indicating a preferential oxidation of carbohy-
drates vs fat, which has been postulated as a mechanism behind
the subsequent development of obesity in this mouse model. In
agreement with these data, our young Il6-KO female mice do
exhibit an increased RER, which could justify at least in part its
higher fat accretion during pregnancy. Additional mechanisms
might include a decrease in energy expenditure in pregnant Il6
deficient mice in comparison to WT controls as a result of an
altered BAT functionality. This option seems plausible in light of
the decreased UCP3 levels and the accumulation of lipid droplets
observed in the BAT of Il6-KO mice at mid pregnancy, which
suggests a reduction in the BAT thermogenic program in our
model [55].
Central acting IL6 has been shown to reduce fat mass by
altering the expression of key hypothalamic factors which control
food intake and energy metabolism [24,27,54,56]. To do so, IL6
binds to its specific cell surface receptor IL6ra which has been
found to be largely expressed in well-known hypothalamic centers
for energy-balance regulation such as the PVN [27] and the ARC
[54]. A novel finding of this study was that Il6 and Il6ra mRNA
levels were down-regulated in the mouse hypothalamus during
pregnancy. Central Il6ra gene expression is known to be activated
in response to systemic immune challenges such as intravenous
injections of lipopolysaccharide (LPS) or the pro-inflammatory
cytokine interleukin-1 (IL1), but also in response to IL6 itself
[57,58]. In addition to its peripheral production, IL6 is also
synthesized in the nervous system with cellular sources being
neurons, astrocytes and microglia, which are recruited to
produced this cytokine in response to different immunogenic
stimulus including LPS endotoxemia [57], but also in response to
overnutrition and obesity [56]. Whether IL6 of both origins plays
distinct or parallel functions in a coordinate manner during
chronic or acute inflammatory conditions has yet to be established.
Whatever is the case, an stimulatory action of centrally produced
IL6 on its own receptor is supported by the fact that acute i.c.v.
IL6 treatment [59], but also astrocyte-specific knockout of Il6 in
female mice [47] has been shown to up-regulate and down-
regulate brain Il6ra mRNA and protein levels. Considering the
above mentioned results, a similar gestational pattern of hypotha-
lamic expression might have been expected for both the ligand and
its receptor. However, our data indicate that in the hypothalamus
of early pregnant mice a reduction of Il6ra mRNA levels occurs
without changes in central Il6 expression and circulating levels.
Furthermore, we also report that lack of the ligand in non-
pregnant and early pregnant animals further down-regulates the
hypothalamic expression of Il6ra. The reason for this discrepancy
is unknown, but it points to the involvement of other factors as
possible modulators of the Il6ra gene transcription during this stage
of pregnancy.
At mid-pregnancy Il6ra mRNA levels returned to non pregnant
values while Il6 gene expression was already reduced. At this
gestational time increased peripheral production of IL6, sourced
from the adipose tissue, as we demonstrate here, and from a yet
fully functional placenta [51,60], might contribute to the high
circulating concentrations of this cytokine in mid-pregnant mice.
These results are in agreement with previous reports showing that
serum IL6 are elevated as early as gestational day 11 in the mouse
[37]. Since we did not measure IL6 CSF levels due to
methodological constrains (low sample volume yields for available
ELISA assays, i.e. only 5 ml/per animal [61]), whether blood-
borne IL6 is able to reach the brain parenchyma and effectively
restore the hypothalamic expression of its receptor remains to be
elucidated. However, in accordance to a stimulatory effect of IL6
(whether of central or peripheral origin) on hypothalamic Il6ra
mRNA levels, we report that lack of Il6 in mid-pregnant animals
Figure 6. Il6-KO decreases hypothalamic Il6ra mRNA content in
early, mid but not in late pregnant mice. 12 weeks old WT and Il6-
KO mice were time-pregnant and RNA was harvested from hypothal-
amus of individual mice at early (n = 5), mid (n = 7–8) and late (n = 6–8).
Age and genotype matched virgin females were used as controls (n = 5–
9). A–C. Il6ra mRNA levels were measured in duplicates, normalized to
18s and expressed as mean 6 SEM. One-way ANOVA, *P,0.05,
**P,0.01 and ****P ,0.0001.
doi:10.1371/journal.pone.0072339.g006
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markedly diminishes its receptor gene expression. In turn, we
provide evidences that at late pregnancy a peripheral low-grade
inflammatory condition, as measured by elevated serum IL6 and
CRP concentrations, is associated with reduced hypothalamic Il6
and Il6ra mRNA levels. Perhaps, these results reflect a decreased
passage of IL6 trough the blood brain barrier, a fact similar to that
described for leptin in late pregnant rodents [28,31,33,35,62],
whose central nervous system become ‘‘ leptin resistant ’’ at the
end of pregnancy when leptinemia increases – thus avoiding the
suppressive effects of leptin on food intake and fat accumulation.
Therefore, the combined effect of a decreased entrance of IL6 into
the CNS and a decreased hypothalamic Il6 gene expression might
contribute to reduce Il6ra mRNA levels. Surprisingly, knockout of
Il6 in late pregnant animals did not affect the hypothalamic
expression of its receptor, probably reflecting a local compensatory
mechanism exerted by other cytokines. In support of this
hypothesis, serum levels of CRP, a systemic marker of inflamma-
tion, did not differ between late pregnant WT and Il6-KO mice
and it has been recently demonstrated that Il1-beta expression is
increased in hypothalamus of obese Il6-KO mice [42,54].
Il6ra is expressed in a number of hypothalamic nuclei involved
in the regulation of energy balance where, as mentioned before, it
mediates the effects of this cytokine on energy expenditure and
thermogenesis. However, the experimental approach used in the
current study was designed to determine global changes in Il6ra
expression in the pregnant mouse hypothalamus, and not to
establish the contribution from individual neuronal populations.
Therefore, in an attempt to further dissect this issue, we analyzed
in our model the transcriptional activity of the main peptidergic
systems involved in this function within the ARC and PVN.
The ARC in particular, where Il6ra is widely expressed, it is
considered as a key integrative center of internal signals encoding
energy status through NPY/AGRP and POMC neurons [7,56].
The results in the present study revealed a differential transcrip-
tional modulation of these genes in the mouse ARC during mid to
late pregnancy from that previously reported in the rat [28,31,38],
probably reflecting a biological difference between species. Thus,
in WT mice the exponential rise in food intake rate observed from
gestational days 13 to 18 seems to be driven by a reduction in Pomc
mRNA levels, while Npy/Agrp expression remains unchanged. A
similar absence of gestational up-regulation of Npy and Agrp
Figure 7. Increased ARC Npy/Agrp and unchanged Pomc mRNA expression in mid and late-pregnant Il6-KO mice. 12 weeks old WT and
Il6-KO mice were time-pregnant and ARC gene expression was assessed by radioactive in situ hybridization in coronal brain sections from early (n = 6–
8), mid (n = 6–9) and late (n = 12–16) pregnant mice. Age and genotype matched virgin females were used as controls (n = 5–16). A–C. Npy (A), Agrp
(B) and Pomc (C) mRNA levels were normalized in percentage to WT virgin control values and expressed as mean 6 SEM (right panel). Representative
in situ hybridization autoradiographic images are shown in the left panel. One-way ANOVA, *P,0.05, **P,0.01 and ***P ,0.001.
doi:10.1371/journal.pone.0072339.g007
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production in the mouse ARC has been previously reported by
some authors [6,63] but not by others [64], the reason for this
discrepancy is unknown but it could be related to the different
methodologies employed (in situ hybridization versus real time-
PCR). Lack of Il6 in mice restored Pomc mRNA content during
mid- to late pregnancy and increased hypothalamic Agrp and Npy
mRNA levels. These data suggest that in absence of IL6 signaling
during latest stages of pregnancy a compensatory mechanism takes
place on POMC and NPY/AGRP neurons, so far allowing
maternal hyperphagia and increased adiposity to be maintained.
In fact, results from a recent report demonstrated that knockout of
Il6 in male mice exerts a similar stimulatory action at the level of
the NPY/AGRP neurons in the ARC after 4 weeks of cold
exposure, i.e. after another extremely energetic challenging
condition [54]. Conversely, exercise-induced hypothalamic IL6
and IL10 in obese rats [56] and Il6 astrocyte-targeted overex-
pression in female mice have been shown to reduce Npy/Agrp
mRNA levels and increase Pomc expression in the ARC [24,65].
Another novel finding in the current study was that, in the
pregnant mouse, expression of Trh in the PVN was up-regulated
during mid-pregnancy and this positive effect was blunted by
knockout of Il6. The PVN acts as a primary integrative center for
peripheral cytokine signaling to CNS and stimulation of a variety
of physiological, neuroendocrine and behavioral CNS responses
including: suppression of food intake, thermogenesis and HPA axis
activation [7]. However, these results were unexpected taking into
account that hypothalamic Pomc mRNA content was depressed at
this gestational time point and TRH neurons in the PVN are
densely innervated by alpha-MSH-producing neurons, which
potently stimulates Trh expression and secretion [8]. The
functional relevance of the Trh transcriptional modulation during
mid-pregnancy remains to be determined but, considering the
important role of this neuropeptide in the regulation of energy
homeostasis and its central effects on thermogenesis [8], a role as
triggering signal of the increase in maternal basal metabolic rate
seen in the latter stages of mouse pregnancy [66] might be
hypothesized. The fact that lack of Il6 in midpregnant mice
reduced the PVN Trh mRNA content to non-pregnant levels was
equally unexpected. Despite the high level of co-expression of Trh
and Il6ra in the mouse hypothalamus [27], published data do not
support a role of IL6 as a direct modulator of Trh gene
transcription [67]. Nevertheless, other pro-inflammatory cytokines
such as TNF alpha and IL1 have been shown to affect the HPT
axis at multiple levels leading to marked decreases in hypothalamic
TRH expression [68]. Whether a compensatory action of this
cytokines on TRH mRNA levels is established in the hypothal-
amus of Il6-KO pregnant mice will merit further investigation.
A final issue to take into account when considering the findings
of the present study is the possible source of experimental
variability induced by the homozygous breeding scheme used to
generate the experimental animals. Due to experimental con-
strains and to ensure genetic homogeneity, we have employed as
breeding founders animals from a C57BL6J-congenic line of IL-6
deficient mice and its corresponding controls from the recipient
strain, all sourced from the same vendor. Although, this breeding
design is being largely used in many studies, it has a potential-
limitation of not taking into account the possible impact of
maternal/paternal genotype, in utero environment and maternal
nursing on the metabolism of the offspring [69].
In summary, we show that pregnancy in the mouse is associated
with a progressive increase in circulating IL6 levels, while
hypothalamic Il6 and Il6ra expression are depressed. This effect
might contribute to a decreased sensitivity to the catabolic action
of IL6 during this physiological state, as shown by increase fat
Figure 8. Increased PVN Trh mRNA content in mid-pregnant WT but not in Il6-KO mice. 12 weeks old WT and Il6-KO mice were time-
pregnant and PVN gene expression was assessed by radioactive in situ hybridization in coronal brain sections from early (n = 8–10), mid (n = 7–12)
and late (n = 12–15) pregnant mice. Age and genotype matched virgin females were used as controls (n = 7–15). A–C. Crh (A) and Trh (B) mRNA levels
were normalized in percentage to WT virgin control values and expressed as mean 6 SEM (right panel). Representative in situ hybridization
autoradiographic images are shown in the left panel. One-way ANOVA, *P,0.05, **P,0.01 and ****P ,0.0001.
doi:10.1371/journal.pone.0072339.g008
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accretion in Il6-KO pregnant mice. Lack of Il6 in mice
differentially modulates the gestational transcriptional profile of
energy balance regulating peptides at the level of the ARC and
PVN, with mayor stimulatory and inhibitory effects on Agrp, Npy
and Pomc as well as Trh gene expression during mid- and late-
pregnancy. Collectively, the results of the present study suggest a
role of IL6 in the central homeostatic mechanisms that regulate
body fat during pregnancy.
Supporting Information
Figure S1 Lean body mass content in WT and Il6-KO
mice during pregnancy. Longitudinal measurements of body
composition were performed in 15 weeks old mice at gestational
days 7, 13 and 18, age and genotype matched virgin females were
used as controls (virgin, n= 5–7 and pregnant n= 9–10/animals
per group). A–B. Lean body mass of virgin and pregnant WT and
Il6-KO mice at the beginning (gestational day 7) and the end of
the experimental period (gestational day 18) as expressed in an
absolute (A) or a relative to weight basis (B). Two-way ANOVA for
repeated measurements, **P,0.01.
(TIF)
Figure S2 Subcutaneous fat mass content in WT and Il6-
KO mice during pregnancy. For transversal analysis of
absolute (right panel) and relative dissected subcutaneous fat mass
(middle and left panel) independent groups of 12 weeks old time-
pregnant mice were sacrificed on gestational days 7 (A, n= 8–9),
13 (B, n= 8–9) and 18 (C, n= 11). Age and genotype matched
virgin females were used as controls (n = 7–11). Relative fat mass
values were calculated in percentage to maternal body weight
(middle panel), excluding the contribution of placentae and fetuses,
and normalized to virgin control values of each genotype (C). Data
are expressed as mean 6 SEM. One-way ANOVA, *P,0.05,
**P,0.01, ***P ,0.001 and ****P,0.0001; two-tailed t-test
#P,0.05 versus corresponding WT pregnant controls.
(TIF)
Figure S3 Decreased serum leptin levels in virgin but
not in late pregnant Il6-KO mice. Circulatin leptin levels
were assessed in 12 weeks old time-pregnant mice (n = 10/group).
Age and genotype matched virgin females were used as controls
(n = 10). Data are expressed as mean 6 SEM. One-way ANOVA,
*P,0.05 and ***P ,0.001.
(TIF)
Figure S4 BAT of mid-pregnant Il6-KO mice show
features of an altered thermogenic program. A–B. Ucp1
(A) and Ucp3 (B) mRNA levels in BAT samples from mid-pregnant
WT and Il6-KO mice as determined by RT-qPCR (n= 7–8). Age
and genotype matched virgin females were used as controls (n = 7–
8). C–D. Protein levels of both thermogenic markers (C, UCP1
and D, UCP3) were also assessed by western-blot (n = 6) and
representative images are shown in the right panels. Data are
expressed as mean 6 SEM. One-way ANOVA, *P,0.05. E.
Representative pictures (106magnification) of BAT samples from
mid-pregnant WT and Il6-KO mice stained with oil-red to
determine the accumulation of neutral fat.
(TIF)
Table S1 Primers and probes used for real-time PCR
and in situ hybridization.
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